Belite Bio (BLTE) Income towards Parent Company (2022 - 2026)

Belite Bio's Income towards Parent Company history runs 5 years deep, the most recent figure standing at -$26.9 million for Q1 2026.

• In Q1 2026, Income towards Parent Company fell 88.68% year-over-year to -$26.9 million; the TTM figure through Mar 2026 stood at -$63.4 billion (down 124.04% YoY), while the FY2025 annual figure was -$75.0 million, down 107.61% from the prior year.
• Income towards Parent Company was -$26.9 million for Q1 2026 at Belite Bio, up from -$25.3 billion in the prior quarter.
• In the past five years, Income towards Parent Company ranged from a high of -$6.8 million in Q4 2022 to a low of -$25.3 billion in Q4 2025.
• Historically, Income towards Parent Company has averaged -$7.4 billion across 5 years, with a median of -$6.9 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Income towards Parent Company plunged 144392.13% in 2024, then jumped 99.82% in 2025.
• A 5-year view of Income towards Parent Company shows it stood at -$6.8 million in 2022, then declined by 3.05% to -$7.0 million in 2023, then slumped by 144392.13% to -$10.1 billion in 2024, then sank by 150.73% to -$25.3 billion in 2025, then jumped by 99.89% to -$26.9 million in 2026.
• The last three Income towards Parent Company figures came in at -$26.9 million (Q1 2026), -$25.3 billion (Q4 2025), and -$21.7 billion (Q3 2025), per Business Quant data.